Alloreactivity but failure to reject human islet transplants by humanized balb/c/Rag2-/-gc-/- mice

Scandinavian Journal of Immunology

Volumn 71, Issue 2, 2010, Pages 83-90

  Jacobson, S ^a   Heuts, F ^b   Juarez, J ^a   Hultcrantz, M ^a   Korsgren, O ^c   Svensson, M ^a   Rottenberg, M ^b   Flodstrom Tullberg M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD34 ANTIGEN;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; KIDNEY; LYMPHOCYTE MIGRATION; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ANIMALS; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FETAL BLOOD; FLOW CYTOMETRY; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 75149133912     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02356.x     Document Type: Article

References (35)

1. Korsgren O, Nilsson B, Berne C et al. Current status of clinical islet transplantation. Transplantation 2005 79: 1289 1293.
2. Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation. Methods Mol Biol 2006 333: 47 104.
3. Hogan A, Pileggi A, Ricordi C. Transplantation: current developments and future directions; the future of clinical islet transplantation as a cure for diabetes. Front Biosci 2008 13: 1192 1205.
4. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004 172: 2731 2738.
5. Roep BO, Atkinson M, von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 2004 4: 989 997.
6. King M, Pearson T, Rossini AA, Shultz LD, Greiner DL. Humanized mice for the study of type 1 diabetes and beta cell function. Ann N Y Acad Sci 2008 1150: 46 53.
7. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988 241: 1632 1639.
8. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988 335: 256 259.
9. Chicha L, Tussiwand R, Traggiai E et al. Human Adaptive Immune System Rag2-/-gammac-/-Mice. Ann N Y Acad Sci 2005 1044: 236 243.
10. Traggiai E, Chicha L, Mazzucchelli L et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004 304: 104 107.
11. Baenziger S, Tussiwand R, Schlaepfer E et al. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/-mice. Proc Natl Acad Sci USA 2006 103: 15951 15956.
12. Berges BK, Akkina SR, Folkvord JM, Connick E, Akkina R. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/-gammac-/-(RAG-hu) mice. Virology 2008 373: 342 351.
13. Gorantla S, Sneller H, Walters L et al. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/-mice. J Virol 2007 81: 2700 2712.
14. Banuelos SJ, Shultz LD, Greiner DL et al. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice. Clin Immunol 2004 112: 273 283.
15. Gregori S, Mangia P, Bacchetta R et al. An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells. J Exp Med 2005 201: 1293 1305.
16. Vlad G, D'Agati VD, Zhang QY et al. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 2008 57: 1878 1886.
17. King M, Pearson T, Shultz LD et al. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol 2008 126: 303 314.
18. Shultz LD, Pearson T, King M et al. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research. Ann N Y Acad Sci 2007 1103: 77 89.
19. Goto M, Eich TM, Felldin M et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004 78: 1367 1375.
20. Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 2003 308: 474 479.
21. Svensson M, Wick MJ. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells. Eur J Immunol 1999 29: 180 188.
22. Shapiro AM, Ricordi C, Hering BJ et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006 355: 1318 1330.
23. Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol 2006 176: 2053 2058.
24. Manz MG. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 2007 26: 537 541.
25. Melkus MW, Estes JD, Padgett-Thomas A et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006 12: 1316 1322.
26. Tonomura N, Shimizu A, Wang S et al. Pig islet xenograft rejection in a mouse model with an established human immune system. Xenotransplantation 2008 15: 129 135.
27. Cupedo T, Mebius RE. Cellular interactions in lymph node development. J Immunol 2005 174: 21 5.
28. Yu CI, Gallegos M, Marches F et al. Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood 2008 112: 3671 3678.
29. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007 7: 118 130.
30. Kirkiles-Smith NC, Harding MJ, Shepherd BR et al. Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation 2009 87: 189 197.
31. Ito M, Kobayashi K, Nakahata T. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. Curr Top Microbiol Immunol 2008 324: 53 76.
32. Huntington ND, Legrand N, Alves NL et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 2009 206: 25 34.
33. Bernard D, Peakman M, Hayday AC. Establishing humanized mice using stem cells: maximizing the potential. Clin Exp Immunol 2008 152: 406 414.
34. Hofer U, Baenziger S, Heikenwalder M et al. RAG2-/-gamma(c)-/-mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J Virol 2008 82: 12145 12153.
35. Sun Z, Denton PW, Estes JD et al. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 2007 204: 705 714.